Mereo BioPharma Group Plc (MREO)

0.3798 +0.01 (+3.52%) USD  |  NASDAQ  |  Oct 02, 16:00
0.3707 -0.01 (-2.40%) Pre-Market: 08:57
More

Mereo BioPharma Group Funds from Operations (TTM)

Funds from Operations (TTM) Chart

View Funds from Operations (TTM) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Funds from Operations (TTM) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 --
March 31, 2026 --
December 31, 2025 --
September 30, 2025 --
June 30, 2025 --
Date Value
March 31, 2025 --
December 31, 2024 --
September 30, 2024 --
June 30, 2024 --
March 31, 2024 --

Funds from Operations Definition

Represents the gross cash flow from the company's operations derived by reconciling net income before the effects of non-cash items.

Read full definition.

Funds from Operations (TTM) Range, Past 5 Years

View Funds from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Funds from Operations (TTM) Benchmarks

View Funds from Operations (TTM) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc Upgrade
BioNTech SE Upgrade
Silence Therapeutics Plc Upgrade
Autolus Therapeutics Plc Upgrade